Why Is Chewy Stock Falling, and is it a Buying Opportunity? | CHWY Stock Analysis
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFA26 Jun 2026, 15:45 UTC
AI-generated source summary
Chewy's fiscal year 2026 sales outlook has been lowered to a range of $13.4 billion to $13.55 billion, down from previous guidance. This adjustment reflects challenging market conditions, including high inflation and increased costs due to tariffs and rising oil prices, which have reduced consumer discretionary spending. First-quarter net sales increased by 7.7% year-over-year to $3.36 billion, with a gross margin of 30.1%. The company also announced the acquisition of SmartEquine to expand its health offerings. Multiple analysts have downgraded price targets for Chewy, citing caution about the company's outlook. Despite these headwinds, the management team is seen as effectively navigating the business, as evidenced by the improvement in operating profit margins and the cash flow to sales ratio, which increased from -3.8% in 2017 to 2% in 2025. The stock's valuation, at a forward P/E of 12.1 and a forward price-to-cash-flow ratio of 9.3, suggests it is trading below its intrinsic value, estimated at $34 by a discounted cash flow model. The stock is currently trading near its 52-week low of $18.22, making it attractive for long-term investors.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.